Treatment of Hypertriglyceridemia with Risk of Pancreatitis

Classification and Risk Assessment

Hypertriglyceridemia severity is classified as: mild (150-199 mg/dL), moderate (200-499 mg/dL), severe (500-999 mg/dL), and very severe (≥1000 mg/dL) 2
Severe and very severe hypertriglyceridemia significantly increase the risk of acute pancreatitis, while mild to moderate levels are primarily associated with cardiovascular disease risk 2, 3
Triglyceride levels ≥1000 mg/dL pose the highest risk for acute pancreatitis and require immediate intervention 4, 3

Implement very low-fat diet (10-15% of calories from fat); for triglycerides ≥1000 mg/dL, extreme restriction to <5% of calories from fat until levels decrease below 1000 mg/dL 4, 5
Eliminate alcohol consumption completely 6, 7
Eliminate added sugars and refined carbohydrates 4, 5
Encourage weight loss in overweight/obese patients 1, 2

Identify and treat secondary causes: uncontrolled diabetes, hypothyroidism, renal disease, liver disease, pregnancy, and medications (thiazides, beta-blockers, estrogen, corticosteroids, antiretrovirals, antipsychotics) 2, 8
Prioritize glycemic control in diabetic patients with very high triglycerides, as this can significantly improve lipid profiles 4, 6

Fibrates are first-line therapy for patients at risk of pancreatitis 1, 2, 8
Prescription omega-3 fatty acids (icosapent ethyl or omega-3 acid ethyl esters) can be added if triglycerides remain elevated 4, 3, 5
Niacin may be considered as part of combination therapy 1, 9

Statins have modest triglyceride-lowering effects (10-15%) and should not be used alone for severe hypertriglyceridemia 1, 2
Consider statins as part of the treatment regimen for patients with moderate hypertriglyceridemia and elevated cardiovascular risk 3, 10
For patients with triglycerides 500-999 mg/dL and ASCVD risk ≥7.5%, statins can be initiated alongside triglyceride-specific therapies 3, 5

Statin plus fibrate combination increases risk of myopathy and rhabdomyolysis; use with caution and monitor creatine kinase levels 10
Statin plus niacin combination has not shown additional cardiovascular benefit and may increase stroke risk; generally not recommended 6, 10

For moderate hypertriglyceridemia, target non-HDL cholesterol to 30 mg/dL higher than LDL goal 1, 2

Pregnancy: Lipid-lowering medications generally contraindicated; management focuses on dietary restrictions 6